ICP 监测设备市场：规模、占有率、法规、报销、程序及 2036 年各细分市场预测

ICP 监测设备是一种医疗仪器，用于测量因神经系统疾病导致脑内压力升高的患者的颅内压 (ICP)。这些神经系统疾病包括创伤性脑损伤、蜘蛛网膜下腔出血、脑积水、脑瘤等。监测 ICP 非常重要，因为脑内压力升高会导致脑损伤和其他严重併发症。

创伤性脑损伤 (TBI) 是使用 ICP 监测设备的主要原因。使用 EVD 进行 ICP 监测被视为黄金标准，因为它提供了 CSF 引流的附加治疗功能。使用 EVD 进行 ICP 监测的一个阻碍因素是，对于脑室较小或脑肿胀的患者，插入 EVD 比较困难。此外，长时间使用 EVD 进行 ICP 监测会增加颅内感染的风险。

本报告对全球 ICP 监测设备市场进行了详细分析，包括竞争格局、 SWOT 分析、 2036 年市场预测、区域和国家趋势。

目录

目前可用的 ICP 监控设备及竞争格局

• 洞察关键产业趋势
• 2015 年至 2036 年 ICP 监测设备各细分市场总收入及市场预测
• 有关单位数量、平均售价和市场价值的详细数据

全球、区域与国家洞察

• ICP 监测设备市场的 SWOT 分析
• ICP 监控设备市场的竞争动态洞察与趋势
• 各国卫生系统概览
• 特定国家的报销政策
• 各国医疗科技法规

ICP Monitoring Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.

ICP monitoring devices are medical devices used to measure intracranial pressure (ICP) in patients with neurological conditions that can cause increased pressure in the brain. These neurological conditions may include traumatic brain injury, subarachnoid hemorrhage, hydrocephalus, and brain tumors. Monitoring ICP is important because increased pressure in the brain can lead to brain damage and other serious complications.

Traumatic brain injury (TBI) is the primary cause of ICP monitoring device usage. ICP monitoring using an EVD is considered as the gold standard as the technique allows an additional therapeutic function of CSF drainage. One factor which limits the use of EVDs for ICP monitoring is the difficulty of inserting the device in patients with small ventricle size or in patients with brain swelling. Also, long term use of EVDs for ICP monitoring increases the risk of intracranial infection.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed ICP Monitoring Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total ICP Monitoring Devices market revenue by segment and market outlooks from 2015-2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for ICP Monitoring Devices market.
• Competitive dynamics insights and trends provided for ICP Monitoring Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Integra LifeSciences Corp, Medtronic Plc, Natus Medical Inc, Spiegelberg GmbH & Co KG, Sophysa SA, Raumedic AG, HpBio Proteses Inc and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the ICP Monitoring Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving ICP Monitoring Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ICP Monitoring Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific ICP Monitoring Devices market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.